The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CSPC Megalith Biopharmaceutical has entered into a license agreement with Radiance Biopharma (9993: HK) for the development and commercialization of SYS6005, a recombinant anti-human receptor tyrosine ...

Radiance Biopharma Inc. bought its way into the ROR1 antibody-drug conjugate (ADC) space through a potential $1 billion-plus licensing deal, including a $15 million up-front payment, with CSPC ...